# Aphria Inc.

Aphria Inc. is an other based in Toronto, Canada.

## Overview

- **Organization type:** other
- **Headquarters:** Toronto, Canada
- **Region:** North America
- **Address:** Toronto, Ontario, Canada
- **Assets under management:** Undisclosed
- **Website:** www.aphria.ca

## Regulatory record

- **Reports private funds:** No

## About

Aphria Inc. was founded as a licensed cannabis producer in Leamington, Ontario, before relocating its corporate headquarters to Toronto. The company went public on the Toronto Stock Exchange in 2014 and later listed on the Nasdaq. Its founding team included executives from the pharmaceutical and agricultural sectors, though specific wealth origin for the entity itself is not publicly disclosed as a single-family office. Aphria's business model centered on large-scale greenhouse cultivation in Leamington, the self-described 'Greenhouse Capital of Canada.' It produced dried flower, oils, and capsules for both medical patients and recreational consumers post-legalization in 2018. The firm also built international distribution through subsidiaries in Germany, Argentina, and Colombia, targeting European and Latin American medical markets. Aphria held stakes in other cannabis firms like SweetWater Brewing and sold beverages under the Good Supply brand. The company employed several thousand workers at peak and operated cultivation facilities spanning more than one million square feet. In 2020, Aphria entered a strategic partnership with Canndoc, an Israeli medical cannabis firm. The defining transactional event was the all-stock merger with Tilray in 2021, creating Tilray Brands, which trades on Nasdaq and holds a global portfolio of cannabis, beverage, and wellness brands. 2021: Aphria completed its merger with Tilray, forming Tilray Brands (per the firm, 2021). Aphria's structure was that of a publicly traded corporation, not a family office or asset manager. Its differentiator was its low-cost greenhouse production model, which aimed to undercut competitors on per-gram pricing. The 2021 merger shifted the entity's identity entirely into Tilray Brands, dissolving the standalone Aphria entity.

## Sectors

- Healthcare Services

## Questions

### Where did Aphria operate?

Aphria's primary cultivation facility was in Leamington, Ontario, Canada. It also held subsidiaries in Germany, Argentina, and Colombia, and partnerships in Israel (public record). Corporate headquarters were in Toronto.

### How did Aphria's merger with Tilray affect its investors?

Shareholders of Aphria received shares of Tilray at a fixed exchange ratio. The merger created Tilray Brands, which reported combined revenue and a global platform (per the firm, 2021).

### Was Aphria involved in international markets?

Yes. Aphria exported medical cannabis to Germany through its subsidiary Aphria Deutschland, and held production assets in Argentina and Colombia (public record). It also had a joint venture in Israel with Canndoc.

### What was Aphria's cultivation approach?

Aphria used greenhouse cultivation in Leamington, Ontario, to lower production costs. The facility spanned over one million square feet and was designed to produce cannabis at scale with lower energy costs (public record).

## Related profiles

- [Bracket Global](https://altss.com/profile/bracket-global)
- [TAG Holdings](https://altss.com/profile/tag-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/aphria-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology